Physician profile
Raya Blackwell
NPI 1194414292
$1,095.03
in general payments reported to CMS, 2019-2025
13 companies · $777 in 2025
The $777 reported for 2025 was more than what 76% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $16.04 · 2024: $302 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,095.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $337.26 | 2024-2025 | Krystexxa, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $185.62 | 2024-2025 | Airsupra, Breztri |
| Corcept Therapeutics | $125.56 | 2025 | Korlym |
| Novo Nordisk INC | $110.29 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Abiomed | $106.72 | 2025 | |
| Lilly USA, LLC | $59.36 | 2024-2025 | Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $44.59 | 2025 | |
| Averitas Pharma INC. | $26.37 | 2024 | Qutenza |
| Penumbra, INC. | $25.55 | 2025 | Indigo System |
| Glaxosmithkline, LLC. | $21.60 | 2024 | Shingrix |
| Exact Sciences Corporation | $18.74 | 2024 | Cologuard Collection Kit |
| Phadia US INC. | $17.09 | 2025 | Immunocap |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.28 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raya Blackwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.